Related references
Note: Only part of the references are listed.Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Kiyomi Morita et al.
NATURE COMMUNICATIONS (2020)
Characteristics of DNMT3A mutations in acute myeloid leukemia
Dong Jin Park et al.
BLOOD RESEARCH (2020)
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
Gunnar Juliusson et al.
BLOOD ADVANCES (2020)
Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup
Laura N. Toth et al.
LEUKEMIA & LYMPHOMA (2019)
Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period
Gunnar Juliusson et al.
BLOOD (2019)
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
Linus Angenendt et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory
Loic Renaud et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome
Emily F. Mason et al.
BLOOD ADVANCES (2019)
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome
Emily F. Mason et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V. Prassek et al.
HAEMATOLOGICA (2018)
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V. Prassek et al.
HAEMATOLOGICA (2018)
Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape
P. Silva et al.
LEUKEMIA (2017)
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
David Grimwade et al.
BLOOD (2016)
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
Klaus H. Metzeler et al.
BLOOD (2016)
Improved Minimal Residual Disease Detection by Targeted Quantitative Polymerase Chain Reaction in Nucleophosmin 1 Type a Mutated Acute Myeloid Leukemia
Louise Pettersson et al.
GENES CHROMOSOMES & CANCER (2016)
Assessment of Minimal Residual Disease in Standard-Risk AML
A. Ivey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
Erik Hulegardh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush et al.
NATURE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes
Yan-Rong Liu et al.
LEUKEMIA RESEARCH (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
Brunangelo Falini et al.
BLOOD (2011)
Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry
Gunnar Juliusson
Clinical Lymphoma Myeloma & Leukemia (2011)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
Kai Ye et al.
BIOINFORMATICS (2009)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease
WC Chou et al.
CANCER RESEARCH (2006)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
dbSNP: a database of single nucleotide polymorphisms
EM Smigielski et al.
NUCLEIC ACIDS RESEARCH (2000)